Changes in Cellular Regulatory Factors Before and After Decompression of Odontogenic Keratocysts

Overview

Journal J Clin Med

Specialty General Medicine

Date 2020 Dec 30

PMID 33374329

Citations 6

Authors

Slmaro Park

Han-Sung Jung

Young-Soo Jung

Woong Nam

Jung Yul Cha

Hwi-Dong Jung

Affiliations

Soon will be listed here.

Abstract

Decompression followed by enucleation, which is one of the treatments used for odontogenic keratocysts (OKCs), is frequently used in OKC lesions of large sizes. This method offers the advantage of minimizing the possibility of sensory impairment without creating a wide-range bone defect; moreover, the recurrence rate can be significantly lower than following simple enucleation. This study aimed to assess the changes in histology and expression of proliferation markers in OKCs before and after decompression treatment. A total of 38 OKC tissue samples from 19 patients who had undergone decompression therapy were examined morphologically and immunohistochemically to observe changes in proliferative activity before and after decompression. The markers used for immunohistochemistry (IHC) staining were Bcl-2, epidermal growth factor receptor (EGFR), Ki-67, P53, PCNA, and SMO. The immunohistochemistry positivity of the 6 markers was scored by using software ImageJ, version 1.49, by quantifying the intensity and internal density of IHC-stained epithelium. The values of Bcl-2, Ki-67, P53, proliferating cell nuclear antigen (PCNA), and SMO in OKCs before and after decompression showed no significant change. No correlation between clinical shrinkage and morphologic changes or expression of proliferation and growth markers could be found. There was no statistical evidence that decompression treatment reduces potentially aggressive behavior of OKC within the epithelial cyst lining itself. This might indicate that decompression does not change the biological behavior of the epithelial cyst lining or the recurrence rate.

Citing Articles

Immunohistochemical Analysis of Dentigerous Cysts and Odontogenic Keratocysts Associated with Impacted Third Molars-A Systematic Review.

Almeida L, Loyd D, Boettcher D, Kraft O, Zammuto S Diagnostics (Basel). 2024; 14(12).

PMID: 38928661 PMC: 11202764. DOI: 10.3390/diagnostics14121246.

OralImmunoAnalyser: a software tool for immunohistochemical assessment of oral leukoplakia using image segmentation and classification models.

Al-Tarawneh Z, Pena-Cristobal M, Cernadas E, Suarez-Penaranda J, Fernandez-Delgado M, Mbaidin A Front Artif Intell. 2024; 7:1324410.

PMID: 38469158 PMC: 10925674. DOI: 10.3389/frai.2024.1324410.

Uncovering lupus nephritis-specific genes and the potential of TNFRSF17-targeted immunotherapy: a high-throughput sequencing study.

Zou X, Yang M, Ye Z, Li T, Jiang Z, Xia Y Front Immunol. 2024; 15:1303611.

PMID: 38440734 PMC: 10909935. DOI: 10.3389/fimmu.2024.1303611.

Significance of EGFR investigation in odontogenic keratocyst: a narrative review.

Vasiljevic V, Obradovic J, Jurisic V Mol Biol Rep. 2023; 50(8):7089-7098.

PMID: 37314601 DOI: 10.1007/s11033-023-08582-3.

Breast cancer dataset with biomarker Biglycan.

Silva Neto P, Kunst R, Barbosa J, Leindecker A, Savaris R Data Brief. 2023; 47:108978.

PMID: 36879615 PMC: 9984769. DOI: 10.1016/j.dib.2023.108978.

References

Li T, BROWNE R, Prime S, Paterson I, Matthews J . p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med. 1996; 25(5):249-55. DOI: 10.1111/j.1600-0714.1996.tb01380.x. View

Stone D, Hynes M, Armanini M, Swanson T, Gu Q, Johnson R . The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature. 1996; 384(6605):129-34. DOI: 10.1038/384129a0. View

Ogden G, Chisholm D, Kiddie R, Lane D . p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J Clin Pathol. 1992; 45(11):1007-10. PMC: 495034. DOI: 10.1136/jcp.45.11.1007. View

Gomes C, Diniz M, Gomez R . Review of the molecular pathogenesis of the odontogenic keratocyst. Oral Oncol. 2009; 45(12):1011-4. DOI: 10.1016/j.oraloncology.2009.08.003. View

Li T, BROWNE R, Matthews J . Quantification of PCNA+ cells within odontogenic jaw cyst epithelium. J Oral Pathol Med. 1994; 23(4):184-9. DOI: 10.1111/j.1600-0714.1994.tb01110.x. View

Rodu B, Tate A, Martinez Jr M . The implications of inflammation in odontogenic keratocysts. J Oral Pathol. 1987; 16(10):518-21. DOI: 10.1111/j.1600-0714.1987.tb00684.x. View

Clark P, Marker P, Bastian H, Krogdahl A . Expression of p53, Ki-67, and EGFR in odontogenic keratocysts before and after decompression. J Oral Pathol Med. 2006; 35(9):568-72. DOI: 10.1111/j.1600-0714.2006.00468.x. View

Schmidt B . The use of liquid nitrogen cryotherapy in the management of the odontogenic keratocyst. Oral Maxillofac Surg Clin North Am. 2007; 15(3):393-405. DOI: 10.1016/S1042-3699(03)00041-4. View

Wang C, Wu H, Katritch V, Han G, Huang X, Liu W . Structure of the human smoothened receptor bound to an antitumour agent. Nature. 2013; 497(7449):338-43. PMC: 3657389. DOI: 10.1038/nature12167. View

10.

Boffano P, Ruga E, Gallesio C . Keratocystic odontogenic tumor (odontogenic keratocyst): preliminary retrospective review of epidemiologic, clinical, and radiologic features of 261 lesions from University of Turin. J Oral Maxillofac Surg. 2010; 68(12):2994-9. DOI: 10.1016/j.joms.2010.05.068. View

11.

Sawhney N, Hall P . Ki67--structure, function, and new antibodies. J Pathol. 1992; 168(2):161-2. DOI: 10.1002/path.1711680202. View

12.

Ahlfors E, Larsson A, Sjogren S . The odontogenic keratocyst: a benign cystic tumor?. J Oral Maxillofac Surg. 1984; 42(1):10-9. DOI: 10.1016/0278-2391(84)90390-2. View

13.

Kimi K, Kumamoto H, Ooya K, Motegi K . Immunohistochemical analysis of cell-cycle- and apoptosis-related factors in lining epithelium of odontogenic keratocysts. J Oral Pathol Med. 2001; 30(7):434-42. DOI: 10.1034/j.1600-0714.2001.300709.x. View

14.

Yu C, Fletcher C, Newman P, Goodlad J, Burton J, Levison D . A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. J Pathol. 1992; 166(2):147-52. DOI: 10.1002/path.1711660210. View

15.

Piattelli A, Fioroni M, Rubini C . Differentiation of odontogenic keratocysts from other odontogenic cysts by the expression of bcl-2 immunoreactivity. Oral Oncol. 1998; 34(5):404-7. DOI: 10.1016/s1368-8375(98)00026-8. View

16.

Morgan T, Burton C, Qian F . A retrospective review of treatment of the odontogenic keratocyst. J Oral Maxillofac Surg. 2005; 63(5):635-9. DOI: 10.1016/j.joms.2004.07.026. View

17.

Anthony Pogrel M, Jordan R . Marsupialization as a definitive treatment for the odontogenic keratocyst. J Oral Maxillofac Surg. 2004; 62(6):651-5. DOI: 10.1016/j.joms.2003.08.029. View

18.

Ninomiya T, Kubota Y, Koji T, Shirasuna K . Marsupialization inhibits interleukin-1alpha expression and epithelial cell proliferation in odontogenic keratocysts. J Oral Pathol Med. 2002; 31(9):526-33. DOI: 10.1034/j.1600-0714.2002.00029.x. View

19.

Herbst R . Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. 2004; 59(2 Suppl):21-6. DOI: 10.1016/j.ijrobp.2003.11.041. View

20.

da Silva Baumgart C, Lauxen I, Filho M, de Quadros O . Epidermal growth factor receptor distribution in pericoronal follicles: relationship with the origin of odontogenic cysts and tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103(2):240-5. DOI: 10.1016/j.tripleo.2005.11.009. View